Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection | Zendy

Keith S. Kaye | Zendy; Tanaya Bhowmick | Zendy; Symeon Metallidis | Zendy; Susan C Bleasdale | Zendy; Olexiy Sagan | Zendy; V.P. Stus | Zendy; José A. Vázquez | Zendy; В. І. Зайцев | Zendy; Mohamed Bidair | Zendy; Erik Chorvat | Zendy; Petru Octavian Drăgoescu | Zendy; Elena Fedosiuk | Zendy; Juan Pablo Horcajada | Zendy; Claudia Murta | Zendy; Y. V. Sarychev | Zendy; Ventsislav Stoev | Zendy; Elizabeth E. Morgan | Zendy; Karen Fusaro | Zendy; David C. Griffith | Zendy; Olga Lomovskaya | Zendy; Elizabeth Alexander | Zendy; Jeffery S. Loutit | Zendy; Michael N. Dudley | Zendy; Evangelos J. GiamarellosBourboulis | Zendy

Open Access

Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection

Author(s) -

Keith S. Kaye,

Tanaya Bhowmick,

Symeon Metallidis,

Susan C Bleasdale,

Olexiy Sagan,

V.P. Stus,

José A. Vázquez,

В. І. Зайцев,

Mohamed Bidair,

Erik Chorvat,

Petru Octavian Drăgoescu,

Elena Fedosiuk,

Juan Pablo Horcajada,

Claudia Murta,

Y. V. Sarychev,

Ventsislav Stoev,

Elizabeth E. Morgan,

Karen Fusaro,

David C. Griffith,

Olga Lomovskaya,

Elizabeth Alexander,

Jeffery S. Loutit,

Michael N. Dudley,

Evangelos J. GiamarellosBourboulis

Publication year - 2018

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2018.0438

Subject(s) - medicine , piperacillin/tazobactam , tazobactam , clinical endpoint , population , adverse effect , randomized controlled trial , intention to treat analysis , surgery , piperacillin , pseudomonas aeruginosa , genetics , environmental health , bacteria , biology

Meropenem-vaborbactam is a combination carbapenem/beta-lactamase inhibitor and a potential treatment for severe drug-resistant gram-negative infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research